Uncomplicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Uncomplicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Effectiveness of Visual Storytelling Intervention on Antibiotic Adherence in UTI Patients [NA]
A completed clinical trial assessing whether a visual storytelling intervention improves antibiotic adherence in patients with uncomplicated…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) [Phase 2]
This is a Phase 2 clinical trial evaluating LBP-EC01 for acute uncomplicated urinary tract infection caused by drug-resistant E. coli; the s…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and microbiology of GSK3882347 in female participants with urinary tract in…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection [Phase 3]
A Phase 3 clinical trial evaluating pivmecillinam hydrochloride tablets for treating uncomplicated urinary tract infection has completed.
-
FDA approval · 2024-03-25FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's original application for fosfomycin tromethamine (fosfomycin trometamol), a generic antibiotic. It is indicated for tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
FDA approval · 2021-10-21FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Kesin Pharma Corporation)
The FDA approved Kesin Pharma Corporation's original ANDA for fosfomycin tromethamine, authorizing the marketing of a generic antibiotic.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women [Phase 3]
Phase 3 trial comparing oral sulopenem-etzadroxil/probenecid to ciprofloxacin for uncomplicated urinary tract infections in adult women; stu…
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community [Phase 4]
Phase 4 trial investigating how prescribing pattern shifts relate to changes in microbial sensitivity in urinary tract infections within a c…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis [Phase 2]
Phase 2 trial comparing oral omadacycline to oral nitrofurantoin for cystitis/ uncomplicated urinary tract infection completed with results …
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs [Phase 3]
Phase 3 trial comparing CLR to fosfomycin trometamol for acute lower urinary tract infections has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Supporting the Improvement and Management of Prescribing for Urinary Tract Infections (SIMPle) [NA]
This is a Clinical Trial Update for the SIMPle trial investigating prescribing improvement and management for uncomplicated urinary tract in…
-
FDA approval · 2013-11-22FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for cefixime. This action updates the cefixime NDA, potentially expanding i…
-
FDA approval · 2012-11-14FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals from Aurobindo Pharma Limited, authorizing a generic version of the…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) [Phase 2]
A Phase 2 trial comparing finafloxacin 300 mg twice daily with ciprofloxacin 250 mg twice daily in patients with lower uncomplicated urinary…
-
FDA approval · 2009-03-05FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for nitrofurantoin monohydrate/macrocyrstalline (Alvogen).
-
FDA approval · 2007-08-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic pr…